ScholarIQanswers from OpenAlex
Analatom (United States)
InstitutionResearch output, impact & collaborations
Analatom (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Analatom (United States)?
ScholarIQrecord summary
Analatom (United States) is a research organisation in Santa Clara, US. OpenAlex records 308 works and 10,652 citations for it. 87 researchers list it as their most recent affiliation.
How many works does Analatom (United States) have?
ScholarIQindexed works
Analatom (United States) has 308 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Analatom (United States) have?
ScholarIQcitation count
Analatom (United States) has 10,652 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Analatom (United States)?
ScholarIQresearcher count
Analatom (United States) has 87 researchers in the ScholarIQ index.
What is the average h-index at Analatom (United States)?
ScholarIQavg h-index
Analatom (United States) has an average h-index of 74 in OpenAlex.
What is the ROR of Analatom (United States)?
ScholarIQror
The ROR for Analatom (United States) is on the source record.
What is the OpenAlex record for Analatom (United States)?
ScholarIQopenalex
The OpenAlex for Analatom (United States) is on the source record.
Who are the most-cited researchers behind Analatom (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Analatom (United States)?
ScholarIQmost cited works
Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases
Jean‐Nicolas Vauthey, Timothy M. Pawlik, Dario Ribero, Tsung‐Teh Wu, Daria Zorzi, Paulo M. Hoff, Henry Q. Xiong, Cathy Eng, Gregory Y. Lauwers, Mari Mino–Kenudson, Mauro Risio, Andrea Muratore, Lorenzo Capussotti, Steven A. Curley, Eddie K. Abdalla
Mucosal Recovery and Mortality in Adults With Celiac Disease After Treatment With a Gluten-Free Diet
Alberto Rubio‐Tapia, Mussarat W Rahim, Jacalyn A. See, Brian D. Lahr, Tsung‐Teh Wu, Joseph A. Murray
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease
Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green, Annette Marcantonio, Tsung‐Teh Wu, Markku Mäki, Daniel C. Adelman, Shoab Ansari, K Ayub, Anna Basile, C. Behrend, P Bercík, Brian Bressler, Valerie Byrnes, Vishal S. Chandan, V. Cheekati, Bradley E. Chipps, Allan Coates, A. Collatrella, John J. Condemi, Clinton N. Corder, Jonathan Corren, C. Martin Curtis, Mark T. DeMeo, Taddese Desta, Christopher E. Devereaux, Anthony J. DiMarino, Marsha Dupree, Craig Ennis, Richard N. Fedorak, Ronald Fogel, Stefanie Freeman, B. Freilich, Keith Friedenberg, Daniel J. Geenen, Kiren Gill, Alan B. Goldsobel, J. Goldstein, Michael J. Goldstein, Glenn L. Gordon, Robert Hardi, Lucinda A. Harris, R.J. Holmes, K. Jagarlamundi, G. James, Mustafa Kaplan, JERZY KIRSTEIN, Anette Knoll, Ronald Kotfila, Richard A. Krause, Alexxai V. Kravitz, Michael Kreines, Marja‐Leena Lähdeaho, Mark Lamet, Keith J. Laskin, Benjamin Lebwohl, Daniel A. Leffler, Suzanne K. Lewis, S. Liakos, Knut E. A. Lundin, K. Marks, K. Merkes, S. Minton, Sam Moussa, V. Narayen, V. Nehra, Eric Newton, Anders Nyberg, Jean L. Oosthuizen, T Otrok, D. Patel, Craig Pepin, R A Phillips, Gail G. Pyle, Mark Reichelderfer, B S Reid, Timothy E. Ritter, Sharanjot Saini, David S. Sanders, Matthew R. Schulman, Carol E. Semrad, Sveta Shah, David H. Stockwell, Cynthia Strout, Daniel Suez, H. Tatum, M. S. Torbenson, Mark S. Turner, Peter Varunok, María I. Vázquez‐Roque, A.R. Vento, Thomas A. Welton, Robert Wohlman, Mariah Wood, Simon Woods, Khalil Yousef
How much of the research on Analatom (United States) is open access?
ScholarIQopen access share
100%OPEN ACCESS